| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |